3,5-Dicaffeoylquinic acid isolated from Artemisia argyi and its ester derivatives exert anti-leucyl-tRNA synthetase of Giardia lamblia (GlLeuRS) and potential anti-giardial effects

Fitoterapia. 2012 Oct;83(7):1281-5. doi: 10.1016/j.fitote.2012.05.016. Epub 2012 Jun 2.

Abstract

An aqueous ethanol extract of Artemisia argyi inhibited the aminoacylation activity of LeuRS from Giardia lamblia (GlLeuRS). The bioassay-guided fractionation of the extract led to the isolation of 3,5-dicaffeoylquinic acid (1), with an IC₅₀ of 5.82 μg/mL. The ester derivatives of 1 were also found to possess strong anti-GlLeuRS effects, with IC₅₀ values of 1.79, 5.51 and 2.56 μg/mL respectively. Anti-giardial assay showed that the derivatives, especially 3,5-dicaffeoylquinic acid propyl ester (4) (IC₅₀=4.62 μg/mL), were effective at killing G. lamblia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoacylation
  • Antiprotozoal Agents / isolation & purification
  • Antiprotozoal Agents / pharmacology*
  • Artemisia / chemistry*
  • Chlorogenic Acid / analogs & derivatives*
  • Chlorogenic Acid / isolation & purification
  • Chlorogenic Acid / pharmacology
  • Giardia lamblia / drug effects*
  • Giardia lamblia / genetics
  • Leucine-tRNA Ligase / antagonists & inhibitors*
  • Parasitic Sensitivity Tests
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*

Substances

  • 3,5-dicaffeoylquinic acid propyl ester
  • Antiprotozoal Agents
  • Plant Extracts
  • Chlorogenic Acid
  • Leucine-tRNA Ligase
  • 3,5-dicaffeoylquinic acid